Table 1.

Five-year incidence rates (2009–2013) for men and women by race

Race
WhiteaBlackAI/ANAPI
Total NnRatenRateRR (95% CI)nRateRR (95% CI)nRateRR (95% CI)
Men
 Esophagus
  Adenocarcinoma4,6394,3725.71211.40.2 (0.2–0.3)283.40.6 (0.4–0.9)1181.00.2 (0.1–0.2)
  Squamous cell1,7961,1081.53884.53.1 (2.7–3.5)152.01.4 (0.7–2.3)2852.31.6 (1.4–1.8)
  Other3042570.3240.30.9 (0.6–1.4)210.20.5 (0.3–0.8)
 Kidney and Renal Pelvis
  Kidney, NOS19,4064,8166.690110.51.6 (1.5–1.7)568.61.3 (1.0–1.7)7086.10.9 (0.9–1.0)
  Renal pelvis1,0829371.3440.60.5 (0.3–0.6)960.80.6 (0.5–0.8)
 Lung and bronchus
  Squamous13,02210,27714.11,54720.61.5 (1.4–1.5)9015.31.1 (0.9–1.4)1,1089.70.7 (0.6–0.7)
  Small cell6,1735,0956.75496.81.0 (0.9–1.1)477.11.1 (0.8–1.4)4824.10.6 (0.6–0.7)
  Adenocarcinoma22,18716,66022.52,64431.41.4 (1.3–1.5)9914.90.7 (0.5–0.8)2,78423.21.0 (1.0–1.1)
  Large cell9267040.91431.71.8 (1.5–2.2)780.60.7 (0.5–0.9)
  Malignant neoplasm and carcinoma unspecified6,4814,8166.690110.51.6 (1.5–1.7)568.61.3 (1.0–1.7)7086.10.9 (0.9–1.0)
 Thyroid
  Papillary6,1375,1006.52622.70.4 (0.4–0.5)384.10.6 (0.4–0.9)7375.40.8 (0.8–0.9)
  Follicular5584330.6520.61.0 (0.7–1.4)690.51.0 (0.7–1.3)
  Medullary1761480.2130.10.7 (0.4–1.3)140.10.6 (0.3–1.0)
  Anaplastic98740.180.10.9 (0.4–2.0)160.11.5 (0.8–2.6)
Women
 Breast
  HR+/HER2+10,9688,1599.61,25710.11.1 (1.0–1.1)1019.71.0 (0.8–1.2)1,4519.00.9 (0.9–1.0)
  HR/HER2+4,8323,3863.96024.91.2 (1.1–1.4)373.70.9 (0.7–1.3)8074.91.2 (1.1–1.3)
  HR+/HER280,31763,60872.47,07559.40.8 (0.8–0.8)49151.80.7 (0.7–0.8)9,14356.80.8 (0.8–0.8)
  Triple-negative12,1438,55510.02,33018.91.9 (1.8–2.0)677.10.7 (0.5–0.9)1,1917.40.7 (0.7–0.8)
 Esophagus
  Adenocarcinoma7847170.8370.30.4 (0.3–0.6)220.10.2 (0.1–0.3)
  Squamous cell1,0577260.82121.82.2 (1.9–2.6)1140.70.9 (0.7–1.1)
  Other110890.1150.11.5 (0.8–2.6)
 Kidney and renal pelvis
  Kidney, NOS10,8078,4509.61,37611.61.2 (1.1–1.3)15516.01.7 (1.4–2.0)8265.20.5 (0.5–0.6)
  Renal pelvis8156630.7580.60.8 (0.6–1.0)910.60.8 (0.6–1.0)
 Lung
  Squamous7,9056,4957.49248.51.2 (1.1–1.2)658.01.1 (0.8–1.4)4212.70.4 (0.3–0.4)
  Small cell6,0685,1855.85665.00.9 (0.8–0.9)475.10.9 (0.6–1.2)2701.70.3 (0.3–0.3)
  Adenocarcinoma24,72018,91121.12,75823.71.1 (1.1–1.2)869.90.5 (0.4–0.6)2,96518.90.9 (0.9–0.9)
  Large cell7475850.71060.91.4 (1.1–1.7)510.30.5 (0.4–0.7)
  Malignant neoplasm and carcinoma unspecified5,1103,9714.46976.01.4 (1.3–1.5)314.00.9 (0.6–1.3)4112.70.6 (0.5–0.7)
 Thyroid
  Papillary20,40115,97320.21,37811.00.5 (0.5–0.6)15215.20.8 (0.6–0.9)2,89818.20.9 (0.9–0.9)
  Follicular1,3811,0251.31791.51.2 (1.0–1.4)141.51.2 (0.6–2.1)1631.00.8 (0.7–1.0)
  Medullary2902370.3330.30.9 (0.6–1.3)190.10.4 (0.3–0.7)
  Anaplastic1671330.1110.10.7 (0.3–1.3)230.21.1 (0.6–1.7)
  • aReference group.

  • ∼Counts of 10 or less were suppressed.